Ubisoft Shares Dip as Assassins Creed Developer Warns of Continuing Losses Michael Saylor Tokenization Could Enable a Free Market for Yield Challenging Traditional Banking ECB Eyes June Rate Increase as Chief Economist Signals Upgraded Economic Forecasts EasyJet Assures Summer Flights Unaffected by Jet Fuel Concerns Amid Iran War Uncertainty Micron Stock Surge Two Numbers That Raise Questions on Valuation US Consumer Sentiment Sinks to Record Low in May as Iran Conflict Stirs Inflation Fears AEVA Q1 2026 Earnings EPS Beat Drives Significant Stock Rally ROP Q1 2026 Earnings Earnings Beat Driven by Strong Execution in Software and Industrial Portfolios NX Q1 2026 Earnings Earnings Beat Estimates Despite Negative EPS ACIW Q1 2026 Earnings EPS Beats Estimates by 1267 Stock Rises Slightly Ethan Allen Interiors Inc ETD Q1 2026 Earnings EPS Beats Estimates by 159 Stock Rises YDKG Q4 2012 Earnings EPS Misses Estimates Amidst Uncertain Operating Environment Oculis Holding AG Warrants OCSAW Hold Steady at 1966 Key Levels in Focus CIT Inc CINT Edges Higher Navigating Key Support and Resistance Levels PRAX Shows Strength Praxis Precision Medicines Gains 245 as Biotech Momentum Builds Astera Labs ALAB Surges 3 Bulls Eye Key Resistance at 322 Amid AIDriven Momentum Galectin Therapeutics GALT Holds Near 250 After Modest Decline IranUS Tensions Escalate Trump Rejects Counterproposal Tehran Vows Defiance Strait of Hormuz Chokepoint in Focus DSWL Q1 2009 Earnings EPS Misses Estimates Stock Moves 029 Palvella Therapeutics PVLA Gains 316 as Bullish Momentum Builds Toward 12347 Resistance Primech Holdings PMEC Declines Over 8 as Selling Pressure Mounts VivoSim Labs Inc VIVS Edges Up 149 as It Tests Resistance at 143 CCU Stock Gains 225 as Chilean Brewer Holds Above Key Support Collegium Pharmaceutical COLL Nears Key Support After Modest Decline InfuSystems Holdings INFU Faces Pressure as Shares Slide 23 Support Test Ahead Kimco Realty Corporation KIM Rallies 141 as Retail REIT Nears Upper Trading Range Dermata Therapeutics DRMA Shares Climb 385 as Stock Tests Key Resistance Levels